SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-23-028474
Filing Date
2023-02-08
Accepted
2023-02-08 16:35:29
Documents
2
Group Members
8VC ENTREPRENEURS FUND I, L.P.8VC FUND I, L.P.8VC GP I, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G d443944dsc13g.htm SC 13G 85577
2 EX-99.1 d443944dex991.htm EX-99.1 6422
  Complete submission text file 0001193125-23-028474.txt   93576
Mailing Address PIER 5, SUITE 101 SAN FRANCISCO CA 94111
Business Address
Lonsdale Joe (Filed by) CIK: 0001832823 (see all company filings)

Type: SC 13G

Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Subject) CIK: 0001854270 (see all company filings)

IRS No.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92581 | Film No.: 23599644
SIC: 2836 Biological Products, (No Diagnostic Substances)